Koninklijke Philips Future Growth
Future criteria checks 3/6
Koninklijke Philips is forecast to grow earnings and revenue by 52.5% and 4.9% per annum respectively. EPS is expected to grow by 51.6% per annum. Return on equity is forecast to be 13.1% in 3 years.
Key information
52.5%
Earnings growth rate
51.6%
EPS growth rate
Medical Equipment earnings growth | 16.2% |
Revenue growth rate | 4.9% |
Future return on equity | 13.1% |
Analyst coverage | Good |
Last updated | 30 Apr 2024 |
Recent future growth updates
Recent updates
Koninklijke Philips: Major Overhang Removed
May 01Koninklijke Philips: Still On The Cautious Line
Jan 24Philips Q3 Earnings: Getting More Attractive (Rating Upgrade)
Oct 25Koninklijke Philips: Hold For Now
Oct 12Philips: A Healthcare Leader But A Very Risky Investment
Sep 20Philips Is Reasonably Valued Despite Its 35% Rally This Year
Jul 07Philips CPAP, BiPAP, ventilator safety reports to FDA top 98K
Feb 10Philips eyes restructuring and job cuts – report
Jan 27Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 20,635 | 1,411 | 1,633 | N/A | 13 |
12/31/2025 | 19,668 | 1,164 | 1,065 | N/A | 14 |
12/31/2024 | 18,681 | 565 | 1,279 | N/A | 12 |
3/31/2024 | 18,140 | -794 | N/A | N/A | N/A |
12/31/2023 | 18,169 | -456 | 1,615 | 2,259 | N/A |
9/30/2023 | 18,529 | -609 | N/A | N/A | N/A |
6/30/2023 | 18,368 | -2,035 | 12 | 766 | N/A |
3/31/2023 | 18,076 | -2,132 | N/A | N/A | N/A |
12/31/2022 | 17,827 | -1,621 | -991 | -185 | N/A |
9/30/2022 | 17,349 | -1,363 | N/A | N/A | N/A |
6/30/2022 | 17,194 | 402 | 2,893 | 3,681 | N/A |
3/31/2022 | 17,247 | 491 | N/A | N/A | N/A |
12/31/2021 | 17,156 | 608 | 4,269 | 5,032 | N/A |
9/30/2021 | 19,669 | 1,173 | N/A | N/A | N/A |
6/30/2021 | 17,703 | 811 | 1,921 | 2,722 | N/A |
3/31/2021 | 19,669 | 1,147 | N/A | N/A | N/A |
12/31/2020 | 17,313 | 991 | 1,745 | 2,640 | N/A |
9/30/2020 | 19,492 | 1,142 | N/A | N/A | N/A |
6/30/2020 | 18,327 | 966 | 1,315 | 2,294 | N/A |
3/31/2020 | 19,490 | 1,055 | N/A | N/A | N/A |
12/31/2019 | 17,147 | 984 | 960 | 1,911 | N/A |
9/30/2019 | 19,110 | 1,354 | N/A | N/A | N/A |
6/30/2019 | 18,714 | 1,452 | 1,063 | 2,024 | N/A |
3/31/2019 | 18,330 | 1,381 | N/A | N/A | N/A |
12/31/2018 | 18,121 | 1,303 | 1,584 | 2,427 | N/A |
9/30/2018 | 17,838 | 1,022 | N/A | N/A | N/A |
6/30/2018 | 17,680 | 871 | 1,403 | 2,232 | N/A |
3/31/2018 | 17,687 | 808 | N/A | N/A | N/A |
12/31/2017 | 17,780 | 814 | N/A | 2,933 | N/A |
9/30/2017 | 17,783 | 830 | N/A | N/A | N/A |
6/30/2017 | 17,792 | 876 | N/A | 3,193 | N/A |
3/31/2017 | 24,724 | 1,105 | N/A | 2,526 | N/A |
12/31/2016 | 17,422 | 788 | N/A | 3,321 | N/A |
9/30/2016 | 19,211 | 218 | N/A | 3,164 | N/A |
6/30/2016 | 20,890 | 248 | N/A | 2,948 | N/A |
3/31/2016 | 22,732 | 365 | N/A | 1,463 | N/A |
12/31/2015 | 16,806 | 145 | N/A | 1,135 | N/A |
9/30/2015 | 23,685 | 590 | N/A | 1,113 | N/A |
6/30/2015 | 23,043 | 228 | N/A | 1,167 | N/A |
3/31/2015 | 22,038 | 191 | N/A | 1,472 | N/A |
12/31/2014 | 21,391 | 225 | N/A | 1,408 | N/A |
9/28/2014 | 20,373 | 437 | N/A | 1,304 | N/A |
6/29/2014 | 20,774 | 839 | N/A | 1,240 | N/A |
3/30/2014 | 21,437 | 974 | N/A | 865 | N/A |
12/31/2013 | 21,990 | 1,031 | N/A | 844 | N/A |
9/29/2013 | 23,231 | 309 | N/A | 1,221 | N/A |
6/30/2013 | 23,457 | 132 | N/A | 1,506 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: PHG is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.4%).
Earnings vs Market: PHG is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: PHG is expected to become profitable in the next 3 years.
Revenue vs Market: PHG's revenue (4.9% per year) is forecast to grow slower than the US market (8.2% per year).
High Growth Revenue: PHG's revenue (4.9% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: PHG's Return on Equity is forecast to be low in 3 years time (13.1%).